- Stem cell research passed both the House and Senate earlier this year. Maybe now the re-introduced measure can survive a veto.
- There is talk about stricter oversight of Plan D, specifically concerning costs.
- Research funding is always important, especially addressing NIH re-authorization passed by the House but not the Senate.
- A bill has been introduced that will allow the FDA to allow low-cost generics for drugs produced from living organisms.
technorati tags: ms, multiplesclerosis, research, congress, advocacy, stemcellresearch, genericdrugs, pland,
2 comments:
Maybe, the MJFox explosion has brought us to the front of the queue for research again. One could hope.
Two can hope. Maybe more.
Post a Comment